vs

Side-by-side financial comparison of PEDEVCO CORP (PED) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $14.5M, roughly 1.6× SS Innovations International, Inc.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -36.8%, a 19.8% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs 79.1%). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 68.6%).

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

PED vs SSII — Head-to-Head

Bigger by revenue
PED
PED
1.6× larger
PED
$23.1M
$14.5M
SSII
Growing faster (revenue YoY)
PED
PED
+39.2% gap
PED
118.2%
79.1%
SSII
Higher net margin
SSII
SSII
19.8% more per $
SSII
-17.0%
-36.8%
PED
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
68.6%
PED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PED
PED
SSII
SSII
Revenue
$23.1M
$14.5M
Net Profit
$-8.5M
$-2.5M
Gross Margin
43.9%
Operating Margin
-21.3%
-3.7%
Net Margin
-36.8%
-17.0%
Revenue YoY
118.2%
79.1%
Net Profit YoY
-243.5%
-28.5%
EPS (diluted)
$-2.23
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PED
PED
SSII
SSII
Q4 25
$23.1M
$14.5M
Q3 25
$7.0M
$12.8M
Q2 25
$7.0M
$10.0M
Q1 25
$8.7M
$5.1M
Q4 24
$10.6M
$8.1M
Q3 24
$9.1M
$4.4M
Q2 24
$11.8M
$4.5M
Q1 24
$8.1M
$3.6M
Net Profit
PED
PED
SSII
SSII
Q4 25
$-8.5M
$-2.5M
Q3 25
$-325.0K
$-3.7M
Q2 25
$-1.7M
$-256.7K
Q1 25
$140.0K
$-5.7M
Q4 24
$5.9M
$-1.9M
Q3 24
$2.9M
$-3.2M
Q2 24
$2.7M
$-4.1M
Q1 24
$773.0K
$-9.8M
Gross Margin
PED
PED
SSII
SSII
Q4 25
43.9%
Q3 25
48.1%
Q2 25
59.1%
Q1 25
21.2%
Q4 24
48.9%
Q3 24
52.8%
Q2 24
31.9%
Q1 24
20.0%
Operating Margin
PED
PED
SSII
SSII
Q4 25
-21.3%
-3.7%
Q3 25
-12.0%
-14.3%
Q2 25
-32.2%
1.0%
Q1 25
1.7%
-115.6%
Q4 24
-12.9%
-22.7%
Q3 24
31.3%
-73.1%
Q2 24
22.3%
-90.9%
Q1 24
7.6%
-270.3%
Net Margin
PED
PED
SSII
SSII
Q4 25
-36.8%
-17.0%
Q3 25
-4.7%
-29.0%
Q2 25
-24.0%
-2.6%
Q1 25
1.6%
-111.0%
Q4 24
56.0%
-23.7%
Q3 24
32.2%
-74.0%
Q2 24
22.7%
-91.8%
Q1 24
9.5%
-270.5%
EPS (diluted)
PED
PED
SSII
SSII
Q4 25
$-2.23
$-0.01
Q3 25
$0.00
$-0.02
Q2 25
$-0.02
$0.00
Q1 25
$0.00
$-0.03
Q4 24
$2.69
$-0.01
Q3 24
$0.03
$-0.02
Q2 24
$0.03
$-0.02
Q1 24
$0.01
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PED
PED
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$3.2M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$207.4M
$38.2M
Total Assets
$375.9M
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PED
PED
SSII
SSII
Q4 25
$3.2M
$3.2M
Q3 25
$10.9M
$5.7M
Q2 25
$8.5M
$11.4M
Q1 25
$10.4M
$15.9M
Q4 24
$4.0M
$466.5K
Q3 24
$4.6M
$220.4K
Q2 24
$6.1M
$608.2K
Q1 24
$13.3M
$948.1K
Stockholders' Equity
PED
PED
SSII
SSII
Q4 25
$207.4M
$38.2M
Q3 25
$115.4M
$39.6M
Q2 25
$115.2M
$42.0M
Q1 25
$116.2M
$40.6M
Q4 24
$115.6M
$13.5M
Q3 24
$106.5M
$13.7M
Q2 24
$103.2M
$14.8M
Q1 24
$100.0M
$16.7M
Total Assets
PED
PED
SSII
SSII
Q4 25
$375.9M
$74.2M
Q3 25
$135.9M
$69.6M
Q2 25
$136.8M
$70.0M
Q1 25
$145.6M
$63.5M
Q4 24
$128.3M
$42.4M
Q3 24
$114.3M
$39.0M
Q2 24
$111.0M
$35.7M
Q1 24
$118.3M
$35.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PED
PED
SSII
SSII
Operating Cash FlowLast quarter
$-2.1M
$-1.5M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PED
PED
SSII
SSII
Q4 25
$-2.1M
$-1.5M
Q3 25
$7.4M
$-7.5M
Q2 25
$-420.0K
$-3.5M
Q1 25
$5.9M
$-6.1M
Q4 24
$4.2M
$-3.3M
Q3 24
$8.3M
$-2.5M
Q2 24
$4.6M
$-1.0M
Q1 24
$-4.3M
$-2.7M
Free Cash Flow
PED
PED
SSII
SSII
Q4 25
$-3.2M
Q3 25
$-8.2M
Q2 25
$-3.8M
Q1 25
$-7.0M
Q4 24
$-3.4M
Q3 24
$-4.2M
Q2 24
$-3.1M
Q1 24
$-2.8M
FCF Margin
PED
PED
SSII
SSII
Q4 25
-22.3%
Q3 25
-64.1%
Q2 25
-37.7%
Q1 25
-136.2%
Q4 24
-41.7%
Q3 24
-96.9%
Q2 24
-69.5%
Q1 24
-76.9%
Capex Intensity
PED
PED
SSII
SSII
Q4 25
11.8%
Q3 25
5.9%
Q2 25
3.2%
Q1 25
17.0%
Q4 24
1.5%
Q3 24
38.8%
Q2 24
46.8%
Q1 24
3.5%
Cash Conversion
PED
PED
SSII
SSII
Q4 25
Q3 25
Q2 25
Q1 25
42.34×
Q4 24
0.71×
Q3 24
2.83×
Q2 24
1.71×
Q1 24
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PED
PED

Segment breakdown not available.

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons